Cardinal Health, Inc. CAH Cash Flow

Cardinal health, inc. (CAH)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10	Dec'09	Sep'09	Jun'09	Mar'09	Dec'08	Sep'08
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
351,000	220,000	-4,921,000	195,000	296,000	280,000	594,000	-1,166,000	255,000	1,053,000	117,000	278,000	382,000	324,000	310,000	335,000	386,000	326,000	384,000	295,000	365,000	289,000	266,000	234,000	315,000	278,000	339,000	-586,000	345,000	304,000	271,000	237,000	333,000	262,000	237,000	202,700	246,100	215,400	294,800	223,300	222,400	234,500	-38,200	273,200	312,800	316,500	249,100
Earnings from discontinued operations, net of tax
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	4,000	-1,000	0	-1,000	1,000	-1,000	1,000	0	-2,000	0	-4,500	-3,400	500	400	29,500	-2,400	51,500	-23,600	71,200	97,800	147,500	76,900
Earnings from continuing operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	234,000	315,000	274,000	340,000	-586,000	346,000	303,000	272,000	236,000	333,000	264,000	237,000	207,200	249,500	214,900	294,400	193,800	224,800	230,200	-61,800	202,000	215,000	169,000	172,200
Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities:
Depreciation and amortization
224,000	230,000	234,000	241,000	261,000	253,000	245,000	253,000	259,000	291,000	229,000	192,000	186,000	166,000	173,000	176,000	159,000	169,000	137,000	115,000	116,000	112,000	108,000	115,000	110,000	117,000	117,000	122,000	99,000	88,000	88,000	86,000	83,000	78,000	78,000	73,800	97,500	73,200	68,500	59,600	68,600	59,500	66,300	57,000	52,700	68,700	47,400
Loss on Sale of Investments
0	0	0	1,000	0	0	2,000	0	0	0	6,000	0	1,000	3,000	0	-	-	-	-	0	0	0	5,000	0	32,000	0	0	-	-	-	-	-	-	-	-	3,500	-3,300	0	74,800	1,700	23,300	20,000	0	0	0	-3,600	3,600
Impairments and (gain)/loss on disposal of assets, net
1,000	-7,000	-1,000	-4,000	-11,000	-8,000	511,000	-1,355,000	6,000	-67,000	-1,000	-3,000	-3,000	-9,000	-3,000	-4,000	0	-17,000	0	-	-	-	-	-	-	-	-	-832,000	-21,000	-5,000	-1,000	-2,000	-17,000	-1,000	-1,000	-17,200	11,800	-1,700	-1,900	800	4,200	400	23,600	-	-	-	-
Gain (Loss) on Extinguishment of Debt
-	-	-	-	-	-	-	-	-	-1,000	-1,000	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-100	0	0	-39,900	0	0	0	0
Share-based compensation
27,000	21,000	20,000	18,000	23,000	22,000	19,000	21,000	24,000	23,000	17,000	23,000	26,000	24,000	23,000	29,000	26,000	26,000	30,000	30,000	27,000	28,000	25,000	24,000	24,000	24,000	24,000	25,000	22,000	22,000	24,000	22,000	21,000	22,000	20,000	19,600	18,000	21,000	21,400	21,000	36,900	20,100	22,000	27,300	32,400	29,200	21,000
Provision for bad debts
39,000	18,000	29,000	29,000	19,000	19,000	21,000	24,000	19,000	15,000	16,000	-10,000	17,000	22,000	7,000	22,000	16,000	18,000	17,000	10,000	16,000	14,000	12,000	11,000	2,000	17,000	12,000	13,000	9,000	8,000	1,000	15,000	5,000	1,000	1,000	4,800	14,400	5,100	2,700	-6,200	11,800	9,100	12,300	6,200	23,400	9,400	12,400
Change in fair value of contingent consideration obligation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-2,000	-13,000	-1,000	8,000	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in operating assets and liabilities, net of effects from acquisitions and divestitures:
Increase in trade receivables
774,000	108,000	-229,000	595,000	-35,000	-111,000	302,000	239,000	15,000	258,000	359,000	558,000	-39,000	-160,000	306,000	145,000	328,000	45,000	348,000	152,000	427,000	0	291,000	548,000	-53,000	-25,000	-1,395,000	-135,000	147,000	-299,000	71,000	439,000	-477,000	98,000	69,000	-121,900	470,400	-163,800	272,300	-386,400	634,600	-985,300	716,100	-268,800	743,800	-619,600	858,200
Increase in inventories
-983,000	1,347,000	-356,000	206,000	-408,000	575,000	178,000	346,000	-130,000	614,000	381,000	-337,000	-284,000	996,000	298,000	-278,000	-108,000	1,070,000	495,000	-71,000	-287,000	1,336,000	-199,000	208,000	-450,000	1,198,000	-1,098,000	27,000	-193,000	329,000	207,000	-375,000	-683,000	1,392,000	161,000	-383,100	-552,200	868,500	731,800	-858,100	-746,100	1,099,100	28,100	-912,500	-476,600	956,200	864,100
Increase in accounts payable
525,000	1,735,000	-1,812,000	1,018,000	-95,000	382,000	559,000	939,000	-472,000	811,000	1,296,000	339,000	-1,338,000	1,284,000	279,000	-24,000	408,000	2,006,000	425,000	291,000	219,000	1,595,000	-157,000	1,196,000	-304,000	764,000	-1,852,000	212,000	183,000	-433,000	464,000	-893,000	94,000	708,000	410,000	-630,400	223,600	729,700	1,033,100	-1,271,700	223,500	496,100	1,003,100	-866,500	335,500	321,000	978,100
Other accrued liabilities and operating items, net
-297,000	83,000	-5,211,000	116,000	-522,000	129,000	84,000	-725,000	-562,000	1,109,000	-239,000	166,000	-202,000	442,000	87,000	121,000	-146,000	-29,000	201,000	16,000	-56,000	-209,000	96,000	139,000	-201,000	-5,000	183,000	447,000	-263,000	93,000	4,000	271,000	-187,000	32,000	13,000	179,000	-221,900	197,500	125,400	35,200	-220,200	159,400	99,600	12,700	-318,400	282,000	4,400
Net cash provided by operating activities-continuing operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	914,200	143,400	217,700	325,000	878,200	522,200	261,600	746,700	710,900	-14,400	-492,000
Net cash provided by operating activities-discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-200	400	-700	-900	1,100	2,400	144,400	-151,700	-93,200	380,800	336,800
Net cash provided by operating activities
1,676,000	697,000	-653,000	506,000	1,480,000	371,000	365,000	554,000	754,000	279,000	1,181,000	724,000	-198,000	554,000	104,000	641,000	919,000	1,463,000	-52,000	868,000	658,000	953,000	61,000	716,000	820,000	37,000	951,000	300,000	989,000	-130,000	568,000	-107,000	893,000	-114,000	504,000	120,200	914,000	143,800	217,000	324,100	879,300	524,600	406,000	595,000	617,700	366,400	-155,200
Cash flows from investing activities:
Acquisition of subsidiaries, net of cash acquired
-	-	-	-	-	-	-	0	1,000	2,000	6,139,000	19,000	102,000	2,000	9,000	231,000	99,000	1,885,000	1,399,000	184,000	233,000	25,000	61,000	351,000	118,000	25,000	25,000	20,000	2,093,000	26,000	100,000	31,000	136,000	0	7,000	5,000	0	1,735,100	559,900	12,800	-12,800	0	32,000	110,100	12,300	0	6,200
Additions to property and equipment
90,000	77,000	72,000	136,000	76,000	58,000	58,000	138,000	78,000	101,000	67,000	94,000	80,000	113,000	100,000	181,000	109,000	92,000	83,000	161,000	56,000	47,000	36,000	111,000	48,000	64,000	26,000	92,000	41,000	36,000	26,000	102,000	57,000	56,000	45,000	107,900	59,800	61,400	61,900	118,200	61,900	42,900	37,000	229,600	61,100	73,100	57,400
Purchase of investments
12,000	3,000	3,000	7,000	1,000	6,000	4,000	2,000	1,000	3,000	3,000	6,000	63,000	73,000	52,000	50,000	62,000	62,000	26,000	208,000	27,000	32,000	75,000	102,000	27,000	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from return of investments
4,000	0	2,000	0	1,000	1,000	1,000	0	0	1,000	64,000	113,000	43,000	38,000	34,000	37,000	42,000	32,000	25,000	77,000	22,000	16,000	91,000	0	47,000	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from Sale of Property, Plant, and Equipment
-	-	0	-	-	-	740,000	-	-	-	1,000	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,500	-500	4,800	-	300	11,600	700
Proceeds from maturities of available-for-sale securities
-	-	-	-	-	-	-	-	-	-	-	28,000	10,000	22,000	17,000	13,000	18,000	14,000	5,000	13,000	8,000	16,000	0	-	-	-	-	0	0	48,000	23,000	46,000	11,000	25,000	10,000	10,000	0	0	0	-	-	-	-	-	-	-	-
Proceeds from sale of CareFusion common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	705,900	300	135,700	135,000	0	-	-	-	-
Net cash provided by/(used in) investing activities-continuing operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,937,500	84,100	21,500	88,100	91,600	-64,200	-216,100	-73,100	-61,500	-62,900
Net cash used in investing activities-discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-100	0	0	-9,900	-57,800	-19,800	-19,900	-31,800
Net cash provided by/(used in) investing activities
-98,000	-78,000	-73,000	-173,000	-84,000	-84,000	679,000	-140,000	781,000	-105,000	-6,144,000	24,000	-192,000	-127,000	-110,000	-399,000	-210,000	-1,993,000	-1,478,000	-463,000	-286,000	-19,000	-81,000	-564,000	-146,000	-89,000	-51,000	-118,000	-2,140,000	-14,000	-103,000	-111,000	-182,000	-42,000	-42,000	-100,200	-74,400	-1,937,500	84,100	21,400	88,100	91,600	-74,100	-273,900	-92,900	-81,400	-94,700
Cash flows from financing activities:
Payment of contingent consideration obligation
-	-	-	-	-	-	-	-	-	-	15,000	-	-	-	0	2,000	0	0	23,000	4,000	3,000	0	0	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Net change in short-term borrowings
-683,000	683,000	-2,000	0	0	0	0	0	-205,000	161,000	-6,000	-22,000	-8,000	8,000	25,000	-8,000	-5,000	3,000	36,000	-3,000	9,000	-58,000	40,000	49,000	-8,000	53,000	20,000	10,000	-28,000	27,000	-10,000	5,000	4,000	9,000	-5,000	4,500	41,500	0	0	-	-	-	-	-	-	99,900	1,200
Purchase of noncontrolling interests
-	-	-	-	-	-	-	0	0	103,000	3,000	0	0	2,000	10,000	0	10,000	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Reduction of long-term obligations
95,000	719,000	74,000	1,100,000	0	1,000	1,000	551,000	0	1,000	402,000	250,000	0	59,000	1,000	1,000	1,000	0	4,000	0	1,000	1,220,000	0	-	-	-	-	299,000	0	2,000	4,000	-	-	-	-	900	218,700	9,000	400	800	300	350,500	1,134,400	-5,700	2,600	153,800	150,700
Proceeds from interest rate swap terminations
-	-	-	-	-	-	-	-	-	-	-	0	0	0	-14,000	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from long-term obligations, net of issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-24,500	3,100	13,300	8,100
Net proceeds/(tax withholdings) from share-based compensation
7,000	2,000	-13,000	-1,000	0	0	-13,000	0	13,000	2,000	-18,000	6,000	20,000	9,000	-9,000	9,000	4,000	14,000	-21,000	13,000	24,000	10,000	25,000	8,000	80,000	64,000	75,000	58,000	37,000	5,000	21,000	19,000	12,000	-7,000	18,000	27,000	25,100	2,500	8,400	15,500	-3,400	-2,200	30,100	500	18,000	2,800	17,900
Excess Tax Benefit from Share-based Compensation, Financing Activities
-	-	-	-	-	-	-	-	-	-	-	-3,000	5,000	2,000	30,000	0	1,000	1,000	31,000	-4,000	14,000	4,000	38,000	3,000	-3,000	27,000	12,000	-	-	-	-	-	-	-	-	-5,300	-5,800	11,200	-14,100	-1,200	-8,700	100	-6,200	-2,700	-2,500	-1,000	3,300
Payment of premiums for debt extinguishment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-400	0	0	66,400	0	0	0	0
Net tax disbursements from share-based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-22,000	-	-	-17,000	17,000	-	-	-	-	-	-	-	11,400	-	-	-	-
Excess tax benefit from exercises of stock options
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,000	-	-	-	-	-	-	-	-
Dividends on common shares
141,000	141,000	146,000	142,000	142,000	143,000	150,000	145,000	140,000	146,000	150,000	142,000	142,000	144,000	149,000	126,000	127,000	128,000	131,000	114,000	113,000	114,000	119,000	103,000	104,000	103,000	105,000	95,000	93,000	81,000	84,000	74,000	74,000	75,000	77,000	68,100	67,900	67,700	70,300	62,800	63,000	63,000	64,200	50,300	50,100	50,300	49,700
Payments for Repurchase of Common Stock
0	0	350,000	0	0	0	600,000	100,000	300,000	0	150,000	0	0	350,000	250,000	-	-	-	-	350,000	0	326,000	360,000	284,000	339,000	0	50,000	250,000	0	0	200,000	150,000	0	0	300,000	200	0	0	269,800	180,000	0	50,000	0	-	-	-	-
Treasury Stock, Value, Acquired, Cost Method
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in financing activities-continuing operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	429,500	-344,200	-228,900	-75,400	-454,200	-1,252,500	-71,300	-135,200	-89,100	-169,900
Net cash provided by financing activities-discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	200	0	0	1,283,800	0	-400	-700	-1,600
Net cash used in financing activities
-912,000	-175,000	-585,000	-1,243,000	-142,000	-144,000	-764,000	-809,000	-637,000	-86,000	-744,000	4,760,000	-128,000	-536,000	-350,000	-479,000	-438,000	-110,000	-112,000	1,028,000	-70,000	-522,000	-376,000	-328,000	-374,000	40,000	-48,000	-586,000	1,201,000	-41,000	-299,000	83,000	-99,000	-57,000	-381,000	-52,500	-225,800	429,500	-344,200	-228,700	-75,400	-454,200	31,300	-71,300	-135,600	-89,800	-171,500
Effect of exchange rates changes on cash and equivalents
4,000	3,000	-8,000	3,000	2,000	-6,000	2,000	-13,000	10,000	-2,000	9,000	3,000	5,000	-11,000	1,000	-5,000	3,000	-10,000	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase/(decrease) in cash and equivalents
670,000	447,000	-1,319,000	-907,000	1,256,000	137,000	282,000	-412,000	926,000	68,000	-5,698,000	5,511,000	-513,000	-120,000	-355,000	-242,000	274,000	-650,000	-1,642,000	1,433,000	302,000	412,000	-396,000	-176,000	300,000	-12,000	852,000	-404,000	50,000	-185,000	166,000	-135,000	612,000	-213,000	81,000	-32,500	613,800	-1,364,200	-43,100	116,800	892,000	162,000	363,200	249,800	389,200	195,200	-421,400
Supplemental Information:
Retained investment in CareFusion at date of Spin-Off
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,600	-2,700	0	863,100	-	-	-	-
Non-cash dividend in connection with Spin-Off
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-14,800	14,900	0	3,688,900	0	0	0	0
Non-cash investing and financing transactions for:
Investment in CareFusion
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0